Cav3.3
102 literature references associated to Cav3.3
1
Yang W
et al.
Cannabinoid receptor agonists modulate calcium channels in rat retinal müller cells.
Neuroscience,
2016
Jan
28
, 313 (213-24).
2
Elíes J
et al.
Regulation of the T-type Ca(2+) channel Cav3.2 by hydrogen sulfide: Emerging controversies concerning the role of H2 S in nociception.
J. Physiol. (Lond.),
2016
Jan
25
, ().
3
Kumar D
et al.
Cacna1c (Cav1.2) Modulates Electroencephalographic Rhythm and Rapid Eye Movement Sleep Recovery.
Sleep,
2015
Sep
, 38 (1371-80).
4
Harraz OF
et al.
CaV1.2/CaV3.x channels mediate divergent vasomotor responses in human cerebral arteries.
J. Gen. Physiol.,
2015
May
, 145 (405-18).
5
Monteil A
et al.
Inhibition of Cav3.2 T-type Calcium Channels by Its Intracellular I-II Loop.
J. Biol. Chem.,
2015
Jun
26
, 290 (16168-76).
6
Elíes J
et al.
H2S does not regulate proliferation via T-type Ca2+ channels.
Biochem. Biophys. Res. Commun.,
2015
Jun
12
, 461 (659-64).
7
Tompkins JD
et al.
Nickel suppresses the PACAP-induced increase in guinea pig cardiac neuron excitability.
Am. J. Physiol., Cell Physiol.,
2015
Jun
1
, 308 (C857-66).
8
Wang Q
et al.
[Effects of bisphenol A on voltage-dependent T-type calcium channels in mouse testis and epididymis, and the role of estrogen receptors].
Wei Sheng Yan Jiu,
2015
Jan
, 44 (23-7).
9
Reynders A
et al.
Transcriptional Profiling of Cutaneous MRGPRD Free Nerve Endings and C-LTMRs.
Cell Rep,
2015
Feb
12
, ().
10
Basson MD
et al.
Increased extracellular pressure stimulates tumor proliferation by a mechanosensitive calcium channel and PKC-β.
Mol Oncol,
2015
Feb
, 9 (513-26).
11
Fukunaga K
[Cognitive Function and Calcium. Cognitive improvement through T type calcium channel stimulation].
Clin Calcium,
2015
Feb
, 25 (247-54).
12
Tomasova L
et al.
Effects of AP39, a novel triphenylphosphonium derivatised anethole dithiolethione hydrogen sulfide donor, on rat haemodynamic parameters and chloride and calcium Cav3 and RyR2 channels.
Nitric Oxide,
2015
Apr
30
, 46 (131-44).
13
Staehlke S
et al.
Intracellular calcium dynamics dependent on defined microtopographical features of titanium.
Biomaterials,
2015
Apr
, 46 (48-57).
14
Elíes J
et al.
Inhibition of T-type Ca(2+) Channels by Hydrogen Sulfide.
Adv. Exp. Med. Biol.,
2015
, 860 (353-60).
15
Calderón-Rivera A
et al.
Regulation of neuronal cav3.1 channels by cyclin-dependent kinase 5 (Cdk5).
PLoS ONE,
2015
, 10 (e0119134).
16
Wang CY
et al.
Meta-Analysis of Public Microarray Datasets Reveals Voltage-Gated Calcium Gene Signatures in Clinical Cancer Patients.
PLoS ONE,
2015
, 10 (e0125766).
17
Watanabe M
et al.
Expression and Regulation of Cav3.2 T-Type Calcium Channels during Inflammatory Hyperalgesia in Mouse Dorsal Root Ganglion Neurons.
PLoS ONE,
2015
, 10 (e0127572).
18
Cazade M
et al.
5,6-EET potently inhibits T-type calcium channels: implication in the regulation of the vascular tone.
Pflugers Arch.,
2014
Sep
, 466 (1759-68).
19
Fekete A
et al.
Presynaptic T-type Ca2+ channels modulate dendrodendritic mitral-mitral and mitral-periglomerular connections in mouse olfactory bulb.
J. Neurosci.,
2014
Oct
15
, 34 (14032-45).
20
González-Ramírez R
et al.
Transcription factor Sp1 regulates T-type Ca(2+) channel CaV 3.1 gene expression.
J. Cell. Physiol.,
2014
May
, 229 (551-60).
21
Cui Y
et al.
Exposure to extremely low-frequency electromagnetic fields inhibits T-type calcium channels via AA/LTE4 signaling pathway.
Cell Calcium,
2014
Jan
, 55 (48-58).
22
Cazade M
et al.
Cross-Modulation and Molecular Interaction at the Cav3.3 Protein between the Endogenous Lipids and the T-Type Calcium Channel Antagonist TTA-A2.
Mol. Pharmacol.,
2014
Feb
, 85 (218-25).
23
Michaela P
et al.
Bisphenol A differently inhibits CaV3.1, Ca V3.2 and Ca V3.3 calcium channels.
Naunyn Schmiedebergs Arch. Pharmacol.,
2014
Feb
, 387 (153-63).
24
Elíes J
et al.
Hydrogen sulfide inhibits Cav3.2 T-type Ca2+ channels.
FASEB J.,
2014
Dec
, 28 (5376-87).
25
Lee SE
et al.
Rebound burst firing in the reticular thalamus is not essential for pharmacological absence seizures in mice.
Proc. Natl. Acad. Sci. U.S.A.,
2014
Aug
12
, 111 (11828-33).
26
Dufour MA
et al.
Somatodendritic ion channel expression in substantia nigra pars compacta dopaminergic neurons across postnatal development.
J. Neurosci. Res.,
2014
Aug
, 92 (981-99).
27
Chemin J
et al.
Modulation of T-type calcium channels by bioactive lipids.
Pflugers Arch.,
2014
Apr
, 466 (689-700).
28
Shuba YM
Models of calcium permeation through T-type channels.
Pflugers Arch.,
2014
Apr
, 466 (635-44).
29
Gangarossa G
et al.
T-type calcium channel Cav3.2 deficient mice show elevated anxiety, impaired memory and reduced sensitivity to psychostimulants.
Front Behav Neurosci,
2014
, 8 (92).
30
Bladen C
et al.
Block of T-type calcium channels by protoxins I and II.
Mol Brain,
2014
, 7 (36).
31
Elies J
et al.
OP20 Inhibition of recombinant T-type Ca(2+) channels by hydrogen sulfide.
Nitric Oxide,
2013
Sep
1
, 31 Suppl 2 (S27-8).
32
Seo H
et al.
Effects of eugenol on T-type Ca2+ channel isoforms.
J. Pharmacol. Exp. Ther.,
2013
Nov
, 347 (310-7).
33
Gouriou Y
et al.
Mitochondrial Ca2+ uptake from plasma membrane Cav3.2 protein channels contributes to ischemic toxicity in PC12 cells.
J. Biol. Chem.,
2013
May
3
, 288 (12459-68).
34
Yue J
et al.
Upregulation of T-type Ca2+ channels in primary sensory neurons in spinal nerve injury.
Spine,
2013
Mar
15
, 38 (463-70).
35
Albéri L
et al.
The calcium-binding protein parvalbumin modulates the firing 1 properties of the reticular thalamic nucleus bursting neurons.
J. Neurophysiol.,
2013
Jun
, 109 (2827-41).
36
Zhang Y
et al.
Modulation of low-voltage-activated T-type Ca²⁺ channels.
Biochim. Biophys. Acta,
2013
Jul
, 1828 (1550-9).
37
Astori S
et al.
Synaptic plasticity at intrathalamic connections via CaV3.3 T-type Ca2+ channels and GluN2B-containing NMDA receptors.
J. Neurosci.,
2013
Jan
9
, 33 (624-30).
38
Boycott HE
et al.
Carbon monoxide inhibition of Cav3.2 T-type Ca2+ channels reveals tonic modulation by thioredoxin.
FASEB J.,
2013
Aug
, 27 (3395-407).
39
Shan HQ
et al.
Ethanol inhibition of a T-type Ca²+ channel through activity of protein kinase C.
Alcohol. Clin. Exp. Res.,
2013
Aug
, 37 (1333-42).
40
Waszkielewicz AM
et al.
Ion channels as drug targets in central nervous system disorders.
Curr. Med. Chem.,
2013
, 20 (1241-85).
41
Sekiguchi F
et al.
T-type calcium channels: functional regulation and implication in pain signaling.
J. Pharmacol. Sci.,
2013
, 122 (244-50).
42
Brennan SC
et al.
Fetal calcium regulates branching morphogenesis in the developing human and mouse lung: involvement of voltage-gated calcium channels.
PLoS ONE,
2013
, 8 (e80294).
43
Wimmer RD
et al.
Sustaining sleep spindles through enhanced SK2-channel activity consolidates sleep and elevates arousal threshold.
J. Neurosci.,
2012
Oct
3
, 32 (13917-28).
44
Lopez-Charcas O
et al.
Block of human CaV3 channels by the diuretic amiloride.
Mol. Pharmacol.,
2012
Oct
, 82 (658-67).
45
Kirkton RD
et al.
Genetic engineering of somatic cells to study and improve cardiac function.
Europace,
2012
Nov
, 14 Suppl 5 (v40-v49).
46
Chevalier M
et al.
Dehydroepiandrosterone (DHEA) inhibits voltage-gated T-type calcium channels.
,
2012
Mar
3
, ().
47
Balderas E
et al.
Niflumic acid blocks native and recombinant T-type channels.
J. Cell. Physiol.,
2012
Jun
, 227 (2542-55).
48
Li CX
et al.
[Distribution diversity of integrins and calcium channels on major human and mouse host cells of Leptospira species].
Zhejiang Da Xue Xue Bao Yi Xue Ban,
2012
Jul
, 41 (410-7).
49
Zhang Y
et al.
Inhibition of T-type Ca(2+) channels by endostatin attenuates human glioblastoma cell proliferation and migration.
,
2012
Jan
10
, ().
50
Kolaj M
et al.
Midline thalamic paraventricular nucleus neurons display diurnal variation in resting membrane potentials, conductances, and firing patterns in vitro.
J. Neurophysiol.,
2012
Apr
, 107 (1835-44).
51
Li Y
et al.
β-Adrenergic stimulation increases Cav3.1 activity in cardiac myocytes through protein kinase A.
PLoS ONE,
2012
, 7 (e39965).
52
Matsunami M
et al.
Chelating luminal zinc mimics hydrogen sulfide-evoked colonic pain in mice: possible involvement of T-type calcium channels.
Neuroscience,
2011
May
5
, 181 (257-64).
53
Hazra R
et al.
A transcriptomic analysis of type I-III neurons in the bed nucleus of the stria terminalis.
,
2011
Feb
7
, ().
54
Yalçın O
Genes and molecular mechanisms involved in the epileptogenesis of idiopathic absence epilepsies.
,
2011
Dec
27
, ().
55
Lacinová L
T-type calcium channel blockers - new and notable.
Gen. Physiol. Biophys.,
2011
Dec
, 30 (403-9).
56
Brunner JI
et al.
Pharmacological validation of candidate causal sleep genes identified in an N2 cross.
J. Neurogenet.,
2011
Dec
, 25 (167-81).
57
Astori S
et al.
The Ca(V)3.3 calcium channel is the major sleep spindle pacemaker in thalamus.
Proc. Natl. Acad. Sci. U.S.A.,
2011
Aug
16
, 108 (13823-8).
58
Lei D
et al.
Anti-epileptic drugs delay age-related loss of spiral ganglion neurons via T-type calcium channel.
Hear. Res.,
2011
Aug
, 278 (106-12).
59
Chen WC
et al.
Complex distribution patterns of voltage-gated calcium channel α-subunits in the spiral ganglion.
Hear. Res.,
2011
Aug
, 278 (52-68).
60
Karmazinova M
et al.
The voltage dependence of gating currents of the neuronal CA(v)3.3 channel is determined by the gating brake in the I-II loop.
Pflugers Arch.,
2011
Apr
, 461 (461-8).
61
Wang Q
et al.
Effects of raloxifene on voltage-dependent T-type Ca2+ channels in mouse spermatogenic cells.
Pharmacology,
2011
, 87 (70-80).
62
David LS
et al.
Splice-variant changes of the Ca(V)3.2 T-type calcium channel mediate voltage-dependent facilitation and associate with cardiac hypertrophy and development.
Channels (Austin),
2010 Sep-Oct
, 4 (375-89).
63
Cain SM
et al.
Contributions of T-type calcium channel isoforms to neuronal firing.
Channels (Austin),
2010 Nov-Dec
, 4 (475-82).
64
Anderson D
et al.
Regulation of the KV4.2 complex by CaV3.1 calcium channels.
Channels (Austin),
2010 May-Jun
, 4 (163-7).
65
Bae J
et al.
Interaction of T-type calcium channel Ca(V)3.3 with the β-subunit.
Mol. Cells,
2010
Sep
, 30 (185-91).
66
Nikitina E
et al.
Alteration in voltage-dependent calcium channels in dog basilar artery after subarachnoid hemorrhage. Laboratory investigation.
J. Neurosurg.,
2010
Oct
, 113 (870-80).
67
Kraus RL
et al.
In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice.
J. Pharmacol. Exp. Ther.,
2010
Nov
, 335 (409-17).
68
Strege PR
et al.
T-type Ca(2+) channel modulation by otilonium bromide.
Am. J. Physiol. Gastrointest. Liver Physiol.,
2010
May
, 298 (G706-13).
69
Johnston J
et al.
Synaptic activation of T-type Ca2+ channels via mGluR activation in the primary dendrite of mitral cells.
J. Neurophysiol.,
2010
May
, 103 (2557-69).
70
Wen XJ
et al.
The roles of T-type calcium channel in the development of neuropathic pain following chronic compression of rat dorsal root ganglia.
Pharmacology,
2010
, 85 (295-300).
71
Barbara G
et al.
T-type calcium channel inhibition underlies the analgesic effects of the endogenous lipoamino acids.
J. Neurosci.,
2009
Oct
21
, 29 (13106-14).
72
Bosch MA
et al.
17Beta-estradiol regulation of the mRNA expression of T-type calcium channel subunits: role of estrogen receptor alpha and estrogen receptor beta.
J. Comp. Neurol.,
2009
Jan
20
, 512 (347-58).
73
Tao J
et al.
Tyrosine kinase-independent inhibition by genistein on spermatogenic T-type calcium channels attenuates mouse sperm motility and acrosome reaction.
Cell Calcium,
2009
Feb
, 45 (133-43).
74
Zhang C
et al.
17Beta-estradiol regulation of T-type calcium channels in gonadotropin-releasing hormone neurons.
J. Neurosci.,
2009
Aug
26
, 29 (10552-62).
75
Inagaki A
et al.
The CaV3.1 T-type Ca2+channel contributes to voltage-dependent calcium currents in rat outer hair cells.
Brain Res.,
2008
Mar
27
, 1201 (68-77).
76
Kang HW
et al.
Distinct contributions of different structural regions to the current kinetics of the Cav3.3 T-type Ca2+ channel.
Biochim. Biophys. Acta,
2008
Dec
, 1778 (2740-8).
77
Chen Y
et al.
Site-directed antibodies to low-voltage-activated calcium channel CaV3.3 (alpha1I) subunit also target neural cell adhesion molecule-180.
Neuroscience,
2007
Mar
30
, 145 (981-96).
78
Blanks AM
et al.
Characterization of the molecular and electrophysiological properties of the T-type calcium channel in human myometrium.
J. Physiol. (Lond.),
2007
Jun
15
, 581 (915-26).
79
Hildebrand ME
et al.
Selective inhibition of Cav3.3 T-type calcium channels by Galphaq/11-coupled muscarinic acetylcholine receptors.
J. Biol. Chem.,
2007
Jul
20
, 282 (21043-55).
80
Traboulsie A
et al.
Subunit-specific modulation of T-type calcium channels by zinc.
J. Physiol. (Lond.),
2007
Jan
1
, 578 (159-71).
81
Sun HS
et al.
Zn2+ sensitivity of high- and low-voltage activated calcium channels.
Biophys. J.,
2007
Aug
15
, 93 (1175-83).
82
Nordskog BK
et al.
Diurnal gene expression patterns of T-type calcium channels and their modulation by ethanol.
Neuroscience,
2006
Sep
1
, 141 (1365-73).
83
Wang J
et al.
CACNA1I is not associated with childhood absence epilepsy in the Chinese Han population.
Pediatr. Neurol.,
2006
Sep
, 35 (187-90).
84
Avila T
et al.
Transforming growth factor-beta1 and bone morphogenetic protein-2 downregulate CaV3.1 channel expression in mouse C2C12 myoblasts.
J. Cell. Physiol.,
2006
Nov
, 209 (448-56).
85
Chevalier M
et al.
T-type CaV3.3 calcium channels produce spontaneous low-threshold action potentials and intracellular calcium oscillations.
Eur. J. Neurosci.,
2006
May
, 23 (2321-9).
86
Park JY
et al.
Activation of protein kinase C augments T-type Ca2+ channel activity without changing channel surface density.
J. Physiol. (Lond.),
2006
Dec
1
, 577 (513-23).
87
Hamid J
et al.
Determinants of the differential gating properties of Cav3.1 and Cav3.3 T-type channels: a role of domain IV?
Neuroscience,
2006
Dec
, 143 (717-28).
88
Wen XJ
et al.
Intrathecal administration of Cav3.2 and Cav3.3 antisense oligonucleotide reverses tactile allodynia and thermal hyperalgesia in rats following chronic compression of dorsal root of ganglion.
Acta Pharmacol. Sin.,
2006
Dec
, 27 (1547-52).
89
Perez-Reyes E
et al.
Molecular biology of T-type calcium channels.
CNS Neurol Disord Drug Targets,
2006
Dec
, 5 (605-9).
90
Perez-Reyes E
Molecular characterization of T-type calcium channels.
Cell Calcium,
2006
Aug
, 40 (89-96).
91
Lory P
et al.
T-type calcium channels in differentiation and proliferation.
Cell Calcium,
2006
Aug
, 40 (135-46).
92
Chemin J
et al.
Molecular pathways underlying the modulation of T-type calcium channels by neurotransmitters and hormones.
Cell Calcium,
2006
Aug
, 40 (121-34).
93
Bourinet E
et al.
Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception.
EMBO J.,
2005
Jan
26
, 24 (315-24).
94
Park JY
et al.
Multiple structural elements contribute to the slow kinetics of the Cav3.3 T-type channel.
J. Biol. Chem.,
2004
May
21
, 279 (21707-13).
95
Mudado MA
et al.
CaV 3.1 and CaV 3.3 account for T-type Ca2+ current in GH3 cells.
Braz. J. Med. Biol. Res.,
2004
Jun
, 37 (929-35).
96
Murbartián J
et al.
Functional impact of alternative splicing of human T-type Cav3.3 calcium channels.
J. Neurophysiol.,
2004
Dec
, 92 (3399-407).
97
Yunker AM
Modulation and pharmacology of low voltage-activated ("T-Type") calcium channels.
J. Bioenerg. Biomembr.,
2003
Dec
, 35 (577-98).
98
Yunker AM
et al.
Immunological characterization of T-type voltage-dependent calcium channel CaV3.1 (alpha 1G) and CaV3.3 (alpha 1I) isoforms reveal differences in their localization, expression, and neural development.
Neuroscience,
2003
, 117 (321-35).
99
Chemin J
et al.
[Functional specificity of T-type calcium channels and their roles in neuronal differentiation]
J. Soc. Biol.,
2003
, 197 (235-47).
100
Zhang Y
et al.
Mutations in high-voltage-activated calcium channel genes stimulate low-voltage-activated currents in mouse thalamic relay neurons.
J. Neurosci.,
2002
Aug
1
, 22 (6362-71).
101
Chemin J
et al.
The alpha1I T-type calcium channel exhibits faster gating properties when overexpressed in neuroblastoma/glioma NG 108-15 cells.
Eur. J. Neurosci.,
2001
Nov
, 14 (1678-86).
102
Mittman S
et al.
Structure and alternative splicing of the gene encoding alpha1I, a human brain T calcium channel alpha1 subunit.
Neurosci. Lett.,
1999
Jul
16
, 269 (121-4).